Skip to main content

La Jolla Pharmaceutical Co

LJPCDelisted Aug 22, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000920465

La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
41
Q2 2022, −4 vs. previous quarter
13F value
$53.9M
Reported value at the end of Q2 2022
Superinvestors holding
0
At the end of Q2 2022

Superinvestors holding LJPC, Q2 2022

Go to the superinvestors tab

No superinvestor reported holding LJPC at the end of Q2 2022.

Latest insider trades

Open-market purchases and sales by La Jolla Pharmaceutical Co insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 6, 2021 (view filing)Dec 2-64 daysRamsay David ADirectorPPurchase+24.5K$3.75+$92.0K+32.5%100.0K after18 lots
Dec 1, 2021 (view filing)7:07 PM ETNov 29-Dec 12 daysTang Kevin C and 3 othersDirector, 10% OwnerSSale−441.3K$3.93−$1.73M−4.4%9.61M after5 lots
Nov 19, 2021 (view filing)Nov 172 daysRamsay David ADirectorPPurchase+7.50K$4.23+$31.7K+11.0%75.5K after

Top 10 13F holders, Q2 2022

The largest institutional positions in La Jolla Pharmaceutical Co at the end of Q2 2022; share changes are against Q1 2022.

See all 41 holders
Institutions holding LJPC in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Tang Capital Management LLC9,607,934$30.6M4.65%00.0%Unchanged
RTW Investments, LP2,327,403$7.42M0.19%00.0%Unchanged
HealthInvest Partners AB1,265,000$4.04M9.30%+558,000+78.9%Added
Vanguard Group Inc825,481$2.63M0.00%00.0%Unchanged
D. E. Shaw & Co., Inc.581,446$1.85M0.00%−18,624−3.1%Reduced
Acadian Asset Management LLC465,247$1.48M0.01%−12,441−2.6%Reduced
BlackRock Inc.418,216$1.33M0.00%−8,297−1.9%Reduced
Tang Kevin C240,000$766.0K99.74%00.0%Unchanged
Geode Capital Management, LLC203,930$650.0K0.00%+1,114+0.5%Added
Bank of New York Mellon Corp122,693$392.0K0.00%−4,391−3.5%Reduced